Not likely, unfortunately. Just not that kind of day.
Utilities and REITS are where it is at today. I hold a handful of those types and they are green. Everything is very red. :(
99.9% of posts here add nothing and seem like they are posted by 10 y.o. kids.with their lame#$%$ IDs and slamming each other. google 'uncleltzz opk' for a message board that is factual and has value. ;)
Excepts of interview: Ronnie Moas (top 3% of WS analysts) of Standpoint Research provided his exclusive insights on the company:
Strong Management: CEO Phillip Frost is crucial to the company’s success. The analyst states, “Opko has highly experienced management; its CEO Dr. Phillip Frost has a proven track record of building and growing two successful biopharma companies.” The analyst also praises Frost’s ability to consistently delivery returns to shareholders, which he also credits for OPKO’s valuation of over $5 billion. The CEO is known for frequent insider trading, often buying shares of his own company in transactions valued from $50,000 to over $7 million. These trades result in a profitable transaction rate of 58% with a 15.8% average return per transaction. The CEO currently owns $1.6 billion (33%) of his company.
Pipeline: Moas praises the company’s strong pipeline, commenting, “OPK has a strong pipeline of drugs and technology, having generated $291 million in revenue in q12016-over 8x versus the same quarter last year.”
the analyst predicts annual sales of $500 million from Rayaldee by 2018.
...4Kscore as a positive catalyst. The 4Kscore is Opko’s unique blood test that identifies the risk of aggressive prostate cancer, marking a $2 billion market opportunity in the U.S. The analyst states, “The 4Kscore test could become a strong revenue generator for the company in the near term,” and predicts annual sales of $200 million or more in the next 2 years. OPK and Tesaro’s breast cancer drug, Varubi, launched in 2015, has also started to generate revenue for the company, with a potential U.S. market opportunity of over $1 billion.
...Rayaldee, Varubi, the 4Kscore, and others, Moas predicts that Opko will continue to grow, with revenues reaching $1.2 billion in 2016 and $2.5 billion in 2018.
Agreed. The potential for this stock is very high. Best to hold and be patient. Patience is the tough part along with watching the price bounce around...for now. ;)
How old are you? 10?
Please people. Put these loser IDs on /ignore. There are SO many that all posts are grey. heh. Or, even better, to go to (google) uncleltzz opk for news and posts that actually mean something.
Shorts will win several battles but the Longs will win the war.
I am uncertain how this will climb. We got a small boost with Ray- but we need more news and earnings to help the future of the stock, IMO.
What I don't doubt is the eventual higher stock price. Shorts, like Happy (below) aren't seeing the big picture.
As a rule, analysts suck. They make 'educated' guesses. No one knows, no one has a crystal ball.
Stocks are like gambling for the most part. Some skill but there's a lot of luck as well., IMO.
I own about 60% what you do but holding and looking towards $20-$30 range for the first goal.
Just being played with as usual. Probably some profit taking by the big boys. It will be a roller coaster for a while. Short term goal for me is 1 year out.
Silly to sell. Best to hold on for 1-2 years if you can take the up-down movement until more news comes out and good revenue numbers each quarter. I'll sell only 1k shares at $14 and then let the rest ride. :)
Let's hope this sticks for the whole day or goes higher. 7.18% at 8:06am! :)
Lots of times it falls off. Either way it is a positive for OPK stockholders (especially those in for the long haul).
Long and Patient since $4s.
Hopefully we won't see below $7 but you never know. If it ever does, I will buy below $8 only.
Below $8 is a bigger possibility if the whole market takes a longer dip. We will see this stock much higher, just could be 1-4 years.
Just how old are you? 12?
What a lame#$%$, immature ID. NO ONE will take anything you say seriously.
Maybe it will make a difference, maybe it won't. Either way, this stock will pay off (though maybe 1-2 years from now). No doubt.
"Opko Health said it is making the move because it feels the Nasdaq is a more appropriate location for its stock. In the press release announcing the shift, Opko Health quoted its CEO Phillip Frost as saying that the exchange "is home to many of the world's best healthcare companies and is a natural fit for OPKO. This move will enhance our public visibility while offering our stockholders cost effective access to advanced trading technologies."
LONG since $4s